Redwood City, CA – October 6, 2009 – Ingenuity Systems, the leading provider of information solutions for life science researchers, and Millennium Science, Ingenuity Systems’ exclusive distributor for Australia and New Zealand, today announced a multi-year deal for Ingenuity Pathway Analysis (IPA) with the Queensland Facility for Advanced Bioinformatics (QFAB). IPA will become a significant component of a unique Integrated Systems Biology platform that has been funded by the Australian Research Council in partnership with the Australian Stem Cell Centre and other institutions. IPA will be used for data analysis and interpretation as part of QFAB’s initiative to enable the global efforts of biotechnology, research biology, drug discovery, and translational medicine.
As part of the bioinformatics platform, IPA will serve as the primary solution to model, analyze, and identify key insights from high-throughput biomolecular data and curated datasets relating to health, biotechnology, and environmental processes. IPA will also help explore biomolecular network models and facilitate experimental validation.
“QFAB felt that IPA’s powerful capabilities made it the perfect solution to include in a unique, state-of-the-art systems biology platform, and we are excited that this integration will help bring better biological insights to our customers in the Australia and the Asia-Pacific regions,” stated Jeremy Barker, Chief Executive Officer, Queensland Facility for Advanced Bioinformatics.
“Advances in technology make it possible to capture and integrate more sophisticated types of data, yet the challenge is still interpreting the results and making informed conclusions. IPA is the ideal tool to rapidly make sense of complex data, which is why we are excited that the QFAB will use IPA as part of its platform,” added Sean Scott, Senior Vice President, Commercial Operations, Ingenuity Systems.
Bren Collinson, Managing Director of Millennium Science, concluded, “This deal highlights the importance of developing and maintaining a solid relationship between Millenium, our customers, and our suppliers, and we are looking forward to working together with QFAB and Ingenuity in the future.”
IPA is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA’s search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.
About Ingenuity Systems®
Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. Our long-term focus on innovation in semantic search has allowed us to create groundbreaking technologies that have one common goal —to generate maximum value from all types of biological and chemical knowledge. Ingenuity offerings leverage the Ingenuity Knowledge Base, which contains uniquely structured literature findings that allow scientists to ask complex biological questions and gain rapid insight into their experimental data or systems of interest. Today, Ingenuity’s solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, academic, and government research institutions worldwide. For more information visit: www.ingenuity.com
About Millennium Science
Millennium Science is a distributor of life science products throughout Australia & New Zealand. Our portfolio is representative of some of the best manufacturers in the business across the disciplines of genomics, proteomics, cell biology and automation. Our ethos is simple: enable your next-generation research.